Prestige Brands Holdings Inc
Johnson & Johnson’s Revenue Trend in 3Q16
In 3Q16, Johnson & Johnson’s (JNJ) top line rose 4.2% to ~$17.8 billion, driven by 4.3% operational growth in revenues.
Bristol-Myers Squibb’s 3Q16 Estimates: Oncology Segment
Opdivo is a human PD-1 blocking antibody used in lung cancer and melanoma treatments. Opdivo is part of BMY’s alliance with Ono Pharmaceutical.
High-Yield Bond Funds Witnessed Small Inflows, Bond Yields Fell
Investor flows into high-yield bond funds were positive last week after two consecutive weeks of negative outflows.
Junk Bond Issuance Rose as Equity Markets Rebounded
Mutual Funds such as the PIMCO High-Yield Fund Class A (PHDAX) and the Fidelity High Income Fund (SPHIX) invest in junk bonds.
High-Yield Bond Issuance Rose after Equity Markets Stabilized
High-yield bond issuance rose last week, with three deals being priced as stock markets rebounded on positive corporate earnings results.